IBL GmbH
IBL GmbH is a privately held, founder-led German engineering services firm (Heppenheim, 6 employees) that provides GMP-compliant product development, specialist planning, and equipment qualification (DQ/IQ/OQ/PQ) to pharmaceutical manufacturers and medical technology companies.
- Company typePrivate
- Founded1996
- HeadquartersHeppenheim, Germany
- Headcount1–10
- GTM typeB2B
- OfferingServices
What IBL GmbH does
IBL GmbH (legal name: IBL Gesellschaft für Ingenieurdienstleistungen mbH) is a privately held German engineering services firm founded in 1996 and headquartered in Heppenheim, Hessen, with registration in Darmstadt (HRB 71185). The company operates with a lean team of six employees under Managing Director Klaus List and is independently owned, with no disclosed external investors, parent entities, or M&A activity. Its core function is to bridge mechanical engineering with the regulatory and process demands of pharmaceutical manufacturing and medical device development.
The company's offerings are organized into three integrated service lines. Produkt- und Technologieentwicklung delivers product engineering for fine-mechanical components, medical products, and test stands, with in-house 3D-printing prototyping used to accelerate design iteration. Fachplanung für pharmazeutische Prozess- und Medizintechnik provides specialist planning of plants and processes, including URS, specifications, risk analyses, FAT, commissioning, and SAT. Anlagenqualifizierung provides GMP-compliant equipment qualification across DQ, IQ, OQ, and PQ phases, including FMEA-moderated risk analysis and traceability matrix maintenance. A network of five named partners (Project Solutions GmbH, NTTF Coating GmbH, JVS Sales Technical GmbH, Dioptic GmbH, Adico Network) extends delivery capacity into coating, optics, technical sales, and project services.
IBL serves pharmaceutical manufacturers and medical technology companies under a quote-based professional services model with multi-year contracts. Customer identities are kept confidential at clients' request, and revenue is not publicly disclosed. The go-to-market is direct enterprise engagement, with the firm operating on reputation, regulatory domain expertise, and partner-supported delivery rather than scale or marketing.
IBL GmbH firmographics
Firmographics- Name
- IBL GmbH
- Legal name
- IBL Gesellschaft für Ingenieurdienstleistungen mbH
- Website
- https://ibl-web.de
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- IBL GmbH is a privately held, founder-led German engineering services firm (Heppenheim, 6 employees) that provides GMP-compliant product development, specialist planning, and equipment qualification (DQ/IQ/OQ/PQ) to pharmaceutical manufacturers and medical technology companies.
- Ownership category
- akta.pro rank
IBL GmbH industry classification
Industry- Product category
- Pharmaceutical & Medical Engineering Services
- NAICS
- Testing Laboratories and Services (54138), Engineering Services (541330)
- SIC
- Services-Testing Laboratories (8734), Special Industry Machinery, Nec (3559)
- akta.pro primary industry
- Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL)
- akta.pro secondary industry
- Reliability, Safety & Risk Engineering (RAMS/PSM) Consulting (BPAHAIAK)
Keywords
Where IBL GmbH is headquartered
LocationHeadquarters
- HQ city
- Heppenheim
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
IBL GmbH business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
Revenue model
- Engineering Services: Provides engineering services including product development, pharmaceutical process technology planning, equipment qualification, and construction supervision. Revenue is generated through project-based consulting and engineering service contracts.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
IBL GmbH product offering
Product offeringCore offering
IBL GmbH provides specialized engineering services to pharmaceutical and medical technology companies, covering product and technology development (medical devices, test stands, fine mechanics), specialist planning for pharmaceutical process and medical technology (project planning, risk analyses, URS, FAT/SAT, GMP documentation), and equipment qualification according to GMP standards (DQ, IQ, OQ, PQ phases) including traceability matrix management and FMEA risk analyses. Services span from initial product idea through prototype (using 3D printing) to series production, with support for supplier management and assembly oversight.
Product overview
IBL GmbH offers three integrated engineering service lines for the pharmaceutical and medical technology industries: Produkt- und Technologieentwicklung (product and technology development) for developing medical devices and production equipment from concept to series; Fachplanung für pharmazeutische Prozess- und Medizintechnik (specialist planning) for project planning, risk analysis, and GMP-compliant documentation; and Anlagenqualifizierung (equipment qualification) for GMP qualification services covering DQ, IQ, OQ, and PQ phases. These services are offered as a coordinated portfolio spanning product development through production qualification.
Differentiator
Problem solved
Functional benefit
Products and services
- Produkt- und Technologieentwicklung Engineering services for product development including fine engineering technology (Feinwerktechnik), medical products, test stands, and optimization of pharmaceutical production equipment. Covers development from prototype using 3D printing through to series production. For pharmaceutical and medical technology companies.
- Fachplanung für pharmazeutische Prozess- und Medizintechnik Specialist planning for pharmaceutical process and medical technology, including project planning of plants and processes, risk analyses, URS, specifications (Lastenheft/Pflichtenheft), FAT, commissioning, SAT, and qualification according to GMP standards. For pharmaceutical and medical technology clients.
- Anlagenqualifizierung Equipment qualification services according to GMP standards, including FMEA-based risk analyses, derivation of qualification measures, test plan and report development (DQ, IQ, OQ, PQ), traceability matrix creation and maintenance, and qualification execution. For pharmaceutical industry clients.
Companies that use IBL GmbH
Customer profileSegments2 records
Ideal customer profiles2 records
IBL GmbH technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
IBL GmbH partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor.
- Project Solutions GmbHminorPartner company providing project solutions services; logo displayed on IBL website partner section.
- JVS Sales Technical GmbHminorSales and technical services partner; logo displayed on IBL website partner section.
- Adico NetworkminorNetwork partner company; logo displayed on IBL website partner section.
Scale indicators2 records
Recent moves4 records
Expansion highlights4 records
IBL GmbH competitors and assessment
Company assessmentDirect peers
- Romaco Group: Romaco is a German manufacturer of processing and packaging machinery for the pharmaceutical industry, with expertise in tablet coating, sterile filling, and aseptic processing. Comparable to IBL because Romaco's pharmaceutical process technology portfolio intersects with IBL's qualification and engineering work for the same German and European pharma manufacturers.
- Glatt Group: Glatt is a German engineering company specializing in process technology for pharmaceutical solid dosage forms, including fluidized bed granulation, coating, and continuous manufacturing. Comparable to IBL because Glatt provides both process engineering and qualification expertise for pharmaceutical production, overlapping with IBL's specialist planning and Anlagenqualifizierung services.
- Harro Höfliger Verpackungsmaschinen GmbH: Harro Höfliger is a German engineering company specializing in pharmaceutical process and packaging machinery for inhalers, injection systems, and diagnostic devices. Comparable to IBL because both develop and qualify inhaler devices, injection systems, and diagnostic test equipment for the same medical-device OEM customers.
- Bausch + Strobel Maschinenfabrik: Bausch + Strobel is a German specialist manufacturer of pharmaceutical filling and closing machines for vials, syringes, and ampoules, with associated qualification services. Comparable to IBL because both serve sterile injectable manufacturing customers and provide GMP-compliant equipment qualification, though Bausch + Strobel is primarily an OEM with broader production scale.
- Optima Group (Optima pharma & life science): Optima Group is a German manufacturer of pharmaceutical filling, processing, and packaging machinery with strong engineering services for sterile and liquid dosage forms. Comparable to IBL because Optima's lyophilization and aseptic filling expertise overlaps directly with IBL's qualification portfolio for freeze-drying lines, sterile filling, and diagnostic test strip production.
Broad incumbents
- Körber Pharma: Körber Pharma is the pharmaceutical business area of Körber Group, providing integrated engineering, software, and inspection solutions for pharma manufacturing. Comparable to IBL because Körber's pharma engineering services target the same GMP qualification and process technology needs IBL serves, though at a much larger portfolio scale.
- Exyte GmbH: Exyte (formerly M+W Group) is the largest German engineering services firm specializing in design, construction, and qualification of high-tech facilities for the pharmaceutical and life sciences industries. Comparable to IBL because both deliver GMP-compliant engineering and qualification services to pharma clients, though Exyte operates at vastly greater scale with full EPC capability.
- GEA Group AG: GEA is a global leader in process engineering for the pharmaceutical and food industries, supplying both equipment and engineering services for aseptic processing, lyophilization, and tablet coating. Comparable to IBL because GEA serves the same pharmaceutical process technology customers IBL qualifies, though GEA is a public multinational equipment OEM rather than a niche consultancy.
- Syntegon Technology GmbH: Syntegon (formerly Bosch Packaging Technology) is a major German process and packaging technology provider for the pharmaceutical industry. Comparable to IBL because Syntegon serves pharmaceutical processing, sterile filling, and inspection machinery customers that IBL qualifies, though Syntegon operates at OEM scale globally.
Emerging players
- Vetter Pharma-Fertigung GmbH & Co. KG: Vetter is a German CDMO specializing in aseptic filling of complex injectable drugs, with deep engineering capability for sterile production equipment. Comparable to IBL because Vetter's sterile injectable process technology and qualification expertise aligns with IBL's GMP qualification and injection system development work.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
IBL GmbH social profiles
Digital presenceIBL GmbH financial estimates
Financial estimateRevenue estimate
Valuation estimate
IBL GmbH leadership team
Management profileNumber of profiles
Profiles6 records
IBL GmbH funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IBL GmbH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IBL GmbH
What does IBL GmbH do?
IBL GmbH provides specialized engineering services to pharmaceutical and medical technology companies, covering product and technology development (medical devices, test stands, fine mechanics), specialist planning for pharmaceutical process and medical technology (project planning, risk analyses, URS, FAT/SAT, GMP documentation), and equipment qualification according to GMP standards (DQ, IQ, OQ, PQ phases) including traceability matrix management and FMEA risk analyses. Services span from initial product idea through prototype (using 3D printing) to series production, with support for supplier management and assembly oversight.
Is IBL GmbH a public or private company?
IBL GmbH is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was IBL GmbH founded?
IBL GmbH was founded in 1996. It employs 1 to 10 people.
Where is IBL GmbH based?
IBL GmbH is headquartered in Heppenheim, Germany, in the Europe region.
How does IBL GmbH make money?
One revenue line is on record: engineering Services.
Who are IBL GmbH's main competitors?
Direct peers on record are Romaco Group, Glatt Group, Harro Höfliger Verpackungsmaschinen GmbH, Bausch + Strobel Maschinenfabrik and Optima Group (Optima pharma & life science). Broad incumbents are Körber Pharma, Exyte GmbH, GEA Group AG and Syntegon Technology GmbH. Vetter Pharma-Fertigung GmbH & Co. KG is listed as an emerging player.
Does IBL GmbH have an API?
No public API is recorded for IBL GmbH.
What industry is IBL GmbH in?
IBL GmbH's product category is Pharmaceutical & Medical Engineering Services. Its primary akta.pro industry code is HLAGAKAL, Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control), with a secondary code of BPAHAIAK, Reliability, Safety & Risk Engineering (RAMS/PSM) Consulting. Its NAICS code is 54138 and its SIC code is 8734.